21.06.2013 Views

Ganong's Review of Medical Physiology, 23rd Edition

Ganong's Review of Medical Physiology, 23rd Edition

Ganong's Review of Medical Physiology, 23rd Edition

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

138 SECTION II <strong>Physiology</strong> <strong>of</strong> Nerve & Muscle Cells<br />

sexual behavior, blood pressure, drinking, pain thresholds,<br />

and regulation <strong>of</strong> the secretion <strong>of</strong> several anterior pituitary<br />

hormones.<br />

CATECHOLAMINES<br />

Norepinephrine & Epinephrine<br />

The chemical transmitter present at most sympathetic postganglionic<br />

endings is norepinephrine. It is stored in the synaptic<br />

knobs <strong>of</strong> the neurons that secrete it in characteristic<br />

small vesicles that have a dense core (granulated vesicles; see<br />

above). Norepinephrine and its methyl derivative, epinephrine,<br />

are secreted by the adrenal medulla, but epinephrine is<br />

not a mediator at postganglionic sympathetic endings. As<br />

discussed in Chapter 6, each sympathetic postganglionic<br />

neuron has multiple varicosities along its course, and each <strong>of</strong><br />

these varicosities appears to be a site at which norepinephrine<br />

is secreted.<br />

There are also norepinephrine-secreting and epinephrinesecreting<br />

neurons in the brain. Norepinephrine-secreting neurons<br />

are properly called noradrenergic neurons, although the<br />

term adrenergic neurons is also applied. However, it seems<br />

appropriate to reserve the latter term for epinephrine-secreting<br />

neurons. The cell bodies <strong>of</strong> the norepinephrine-containing<br />

neurons are located in the locus ceruleus and other medullary<br />

and pontine nuclei (Figure 7–2). From the locus ceruleus, the<br />

axons <strong>of</strong> the noradrenergic neurons form the locus ceruleus<br />

system. They descend into the spinal cord, enter the cerebellum,<br />

and ascend to innervate the paraventricular, supraoptic,<br />

and periventricular nuclei <strong>of</strong> the hypothalamus, the thalamus,<br />

the basal telencephalon, and the entire neocortex.<br />

Biosynthesis & Release <strong>of</strong> Catecholamines<br />

The principal catecholamines found in the body—norepinephrine,<br />

epinephrine, and dopamine—are formed by hydroxylation<br />

and decarboxylation <strong>of</strong> the amino acid tyrosine<br />

(Figure 7–1). Some <strong>of</strong> the tyrosine is formed from phenylalanine,<br />

but most is <strong>of</strong> dietary origin. Phenylalanine hydroxylase<br />

is found primarily in the liver (see Clinical Box 7–3). Tyrosine<br />

is transported into catecholamine-secreting neurons and adrenal<br />

medullary cells by a concentrating mechanism. It is converted<br />

to dopa and then to dopamine in the cytoplasm <strong>of</strong> the<br />

cells by tyrosine hydroxylase and dopa decarboxylase. The<br />

decarboxylase, which is also called aromatic L-amino acid decarboxylase,<br />

is very similar but probably not identical to 5-hydroxytryptophan<br />

decarboxylase. The dopamine then enters<br />

the granulated vesicles, within which it is converted to norepinephrine<br />

by dopamine β-hydroxylase (DBH). L-Dopa is the<br />

isomer involved, but the norepinephrine that is formed is in<br />

the D configuration. The rate-limiting step in synthesis is the<br />

conversion <strong>of</strong> tyrosine to dopa. Tyrosine hydroxylase, which<br />

catalyzes this step, is subject to feedback inhibition by dopamine<br />

and norepinephrine, thus providing internal control <strong>of</strong><br />

the synthetic process. The c<strong>of</strong>actor for tyrosine hydroxylase is<br />

CLINICAL BOX 7–3<br />

Phenylketonuria<br />

Phenylketonuria is a disorder characterized by severe mental<br />

deficiency and the accumulation in the blood, tissues, and<br />

urine <strong>of</strong> large amounts <strong>of</strong> phenylalanine and its keto acid<br />

derivatives. It is usually due to decreased function resulting<br />

from mutation <strong>of</strong> the gene for phenylalanine hydroxylase.<br />

This gene is located on the long arm <strong>of</strong> chromosome 12. Catecholamines<br />

are still formed from tyrosine, and the cognitive<br />

impairment is largely due to accumulation <strong>of</strong> phenylalanine<br />

and its derivatives in the blood. Therefore, it can be treated<br />

with considerable success by markedly reducing the amount<br />

<strong>of</strong> phenylalanine in the diet. The condition can also be<br />

caused by tetrahydrobiopterin (BH4) deficiency. Because<br />

BH4 is a c<strong>of</strong>actor for tyrosine hydroxylase and tryptophan<br />

hydroxylase, as well as phenylalanine hydroxylase, cases due<br />

to tetrahydrobiopterin deficiency have catecholamine and<br />

serotonin deficiencies in addition to hyperphenylalaninemia.<br />

These cause hypotonia, inactivity, and developmental problems.<br />

They are treated with tetrahydrobiopterin, levodopa,<br />

and 5-hydroxytryptophan in addition to a low-phenylalanine<br />

diet. BH4 is also essential for the synthesis <strong>of</strong> nitric oxide (NO)<br />

by nitric oxide synthase. Severe BH4 deficiency can lead to<br />

impairment <strong>of</strong> NO formation, and the CNS may be subjected<br />

to increased oxidative stress.<br />

tetrahydrobiopterin, which is converted to dihydrobiopterin<br />

when tyrosine is converted to dopa.<br />

Some neurons and adrenal medullary cells also contain the<br />

cytoplasmic enzyme phenylethanolamine-N-methyltransferase<br />

(PNMT), which catalyzes the conversion <strong>of</strong> norepinephrine<br />

to epinephrine. In these cells, norepinephrine apparently<br />

leaves the vesicles, is converted to epinephrine, and then enters<br />

other storage vesicles.<br />

In granulated vesicles, norepinephrine and epinephrine are<br />

bound to ATP and associated with a protein called chromogranin<br />

A. In some but not all noradrenergic neurons, the<br />

large granulated vesicles also contain neuropeptide Y. Chromogranin<br />

A is a 49-kDa acid protein that is also found in<br />

many other neuroendocrine cells and neurons. Six related<br />

chromogranins have been identified. They have been<br />

claimed to have multiple intracellular and extracellular functions.<br />

Their level in the plasma is elevated in patients with a<br />

variety <strong>of</strong> tumors and in essential hypertension, in which they<br />

probably reflect increased sympathetic activity. However,<br />

their specific functions remain unsettled.<br />

The catecholamines are transported into the granulated<br />

vesicles by two vesicular transporters, and these transporters<br />

are inhibited by the drug reserpine.<br />

Catecholamines are released from autonomic neurons and<br />

adrenal medullary cells by exocytosis. Because they are present<br />

in the granulated vesicles, ATP, chromogranin A, and the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!